Written by Klarity Editorial Team
Published: Aug 23, 2026

Last updated: August 23, 2026
Trifluoperazine is a first-generation (typical) phenothiazine antipsychotic. Tablets come as 1 mg, 2 mg, 5 mg, and 10 mg. The historic brand Stelazine is discontinued. Generic tablets remain. Trifluoperazine is not a controlled substance. The FDA label lists two adult uses: management of schizophrenia, and short-term treatment of generalized non-psychotic anxiety under tight dose and duration limits.
This guide covers what trifluoperazine treats, how anxiety and psychosis dosing differ, why tardive dyskinesia and the dementia boxed warning matter, and which parts of care a telehealth visit can handle. It is educational, not a diagnosis or a promise that any plan will pay for a specific medicine.
See if you may qualify for online mental health care →
According to MedlinePlus (revised November 15, 2025), trifluoperazine treats schizophrenia and anxiety. It belongs to the antipsychotic class and reduces abnormal excitement in the brain. Tablets are taken one or two times a day. Brand name: Stelazine (discontinued).
The DailyMed trifluoperazine tablet label lists film-coated tablets equivalent to 1 mg, 2 mg, 5 mg, or 10 mg trifluoperazine. DEA schedule: none. The 10 mg tablet is labeled for use only in severe neuropsychiatric conditions.
DailyMed indications:
For non-psychotic anxiety, DailyMed says not to go above 6 mg per day or treat longer than 12 weeks. Higher doses or longer courses may cause persistent tardive dyskinesia that can prove irreversible. Effectiveness for this anxiety use came from a four-week multicenter outpatient study of generalized anxiety disorder (DSM-III). That study does not predict benefit in other settings where anxiety or anxiety-like signs appear (physical illness, organic mental conditions, agitated depression, character pathologies). DailyMed also states trifluoperazine has not been shown effective for behavioral complications in people with mental retardation.
Providers sometimes use trifluoperazine off-label. Off-label use needs a clear clinical reason and a discussion of alternatives.
MedlinePlus: tablets by mouth, once or twice a day, at about the same times. The prescriber usually starts low and may raise the dose, then lower it once symptoms are controlled. Trifluoperazine controls symptoms; it does not cure the condition. Do not stop suddenly. Abrupt stop can cause nausea, vomiting, dizziness, and shakiness. Taper.
DailyMed dosing:
Missed dose (MedlinePlus): take it when you remember unless the next dose is near. Do not double up.
Browse conditions and next steps →
Common effects from MedlinePlus include dizziness or unsteadiness, blurred vision, dry mouth, difficulty urinating, agitation or insomnia, unusual or slowed movements, weakness, breast enlargement or milk production, missed periods, and lower sexual function in men.
Serious effects that need urgent care:
DailyMed boxed warning: older adults with dementia-related psychosis have a higher death risk on antipsychotics. Trifluoperazine is not approved for dementia-related psychosis. MedlinePlus repeats that warning.
MedlinePlus: trifluoperazine can raise sun sensitivity and make it harder to cool down in heat. Home pregnancy tests can be unreliable. Do not rely on a home kit. Anyone who handles tablets should avoid touching them directly; there is a small chance of a contact rash. Tell clinicians before a myelogram; the medicine is often held for 2 days before and 1 day after.
DailyMed contraindications:
MedlinePlus also flags extra caution for pheochromocytoma, breast cancer, glaucoma, balance problems, seizures, chest pain or heart disease, planned work with organophosphorus insecticides, and prior severe reactions to psychiatric medicines. Alcohol can worsen sedation. Do not drive until you know how you react. Stand up slowly.
Overdose (MedlinePlus): sleepiness, loss of consciousness, unusual movements, agitation, fever, seizures, dry mouth, irregular heartbeat. Poison Control: 1-800-222-1222.
HHS notes that telehealth remains widely used for behavioral health and can improve access and continuity. A survey of mental health treatment facilities found 80% offered care via telehealth. A licensed telehealth clinician can review history, discuss oral antipsychotic options, check side effects, and coordinate labs when needed.
Trifluoperazine is not a controlled substance, so federal scheduling is not the barrier. Schizophrenia care still needs a careful diagnosis, a plan for movement side effects, and a path to in-person or emergency care if NMS, severe dystonia, or acute psychosis appears. Anxiety use on this drug is short-term and capped at 6 mg/day. Many people with anxiety start with other options first. Pediatric psychosis dosing on the label assumes hospital or close supervision.
Klarity Health works with 2,000+ licensed providers. Many people use telehealth for depression, anxiety, and related medication follow-up. Coverage for visits and medicines varies by plan. Verify benefits before you book. If you already take an antipsychotic such as perphenazine (Trilafon) or fluphenazine (Prolixin), a clinician can compare classes rather than switch you without a reason. Anxiety-focused care may also start at online anxiety treatment.
Need immediate support? Call or text 988 (Suicide & Crisis Lifeline). If someone cannot stay safe, call 911.
Many commercial and Medicare plans may cover generic oral trifluoperazine. Prior authorization is common for antipsychotics. Coverage varies by plan. Confirm benefits, copays, and pharmacy network rules before you rely on a specific fill.
This article does not state that any insurer covers trifluoperazine. A Klarity visit is a clinical evaluation. A prescription is never guaranteed.
Stelazine was the brand name. MedlinePlus marks Stelazine as discontinued. Generic 1, 2, 5, and 10 mg tablets remain.
No. DailyMed lists DEA schedule as none.
DailyMed: start 2 to 5 mg twice daily. Most people respond around 15 to 20 mg daily. A few need 40 mg or more. Reach an optimum level within two or three weeks, then maintain at the lowest dose that holds symptoms.
A clinician can discuss anxiety options. The label is not first-line for most non-psychotic anxiety and caps use at 6 mg per day for no more than 12 weeks because of tardive dyskinesia risk. Many people start with other medicines or therapy instead.
MedlinePlus: trifluoperazine may interfere with home pregnancy test results. Talk with a clinician if pregnancy is possible. Do not rely on a home kit.
Trifluoperazine is a typical phenothiazine antipsychotic for schizophrenia and for short-term, low-dose non-psychotic anxiety. Tablets come as 1, 2, 5, and 10 mg. Psychosis starts often sit at 2 to 5 mg twice daily, with many people settling near 15 to 20 mg daily. Anxiety use stays at 1 to 2 mg twice daily, not above 6 mg or 12 weeks. Boxed warning: dementia-related psychosis. Telehealth can support evaluation and oral follow-up. It cannot replace emergency or inpatient care when NMS, severe EPS, or acute psychosis appears.
Disclaimer: This article is for education only. It is not medical advice, a diagnosis, or a guarantee of insurance coverage. Coverage varies by plan. Verify benefits before booking. Talk with a licensed clinician about your own care. If you are in crisis, call or text 988 or call 911.
Find the right provider for your needs — select your state to find expert care near you.